Get the Stockscreener App
2.13
9.36%
-0.22
After Hours:
2.10
-0.03
-1.41%
Bone Biologics Corp stock is traded at $2.13, with a volume of 285.13K.
It is down -9.36% in the last 24 hours and up +52.14% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$2.35
Open:
$2.35
24h Volume:
285.13K
Relative Volume:
0.06
Market Cap:
$3.84M
Revenue:
-
Net Income/Loss:
$-8.95M
P/E Ratio:
-0.2318
EPS:
-9.19
Net Cash Flow:
$-9.56M
1W Performance:
+9.79%
1M Performance:
+52.14%
6M Performance:
+0.00%
1Y Performance:
+199.96%
1-Day Range:
$2.10
$2.4499
1-Week Range:
$1.9602
$2.75
52-Week Range:
$0.3701
$10.56
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Bone Biologics Corp Stock (BBLG) Latest News
Ortho Biological Products Market Giants Spending Is Going to Boom - La Funcion mx
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Orthobiologics Market Industry Analysis 2024 Future Scope, - openPR
A closer look at BBLG’s price-to-free cash flow ratio - US Post News
Bone Biologics Corp (BBLG) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Wall Street today: US stocks surge stops as investors pause after big US Fed rate cut, Nike gains 6.59% | Stock Market News - Mint
Bone Biologics Corp [BBLG] Is Currently 20.23 above its 200 Period Moving Avg: What Does This Mean? - The DBT News
Orthobiologics Market See Incredible Growth 2024-2031 | Zimmer - openPR
SLNO Skyrockets 800%, BWAY Blasts Past 400%Were You On Board? - RTTNews
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors - CNBC
BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Update - MarketBeat
Bausch Reportedly Eyes A Sale; Could J&J Or AbbVie Buy It? - Investor's Business Daily
Nothing is Better Than Bone Biologics Corp (BBLG) stock at the moment - SETE News
Orthobiologics Market 2024 SWOT Analysis, Key Business Strategies by Leading Industry Players and Forecast 2033 - Cauverynews
Reviewing BioLargo (NASDAQ:BLGO) and Loop Industries (NASDAQ:LOOP) - Defense World
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - Investing.com UK
Why Bausch + Lomb Rallied Today - The Motley Fool
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues - AOL
Bausch + Lomb Stock Jumps Amid Reports Of A Sale - Investopedia
BBLG’s price-to-free cash flow ratio: What it means for investors - US Post News
Bone Biologics Corp’s Banking’s 100-Day Moving Average at 1.5338: Will the Stock Break Through? - The InvestChronicle
Bone Biologics rises 5% on $2M equity offering - MSN
Bausch & Lomb shares jump on spin-off sale hopes - ShareCast
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
M&A News: Bausch+Lomb (NYSE:BLCO) Potentially Exploring Sale Amid Parent Company’s Debt Struggles - TipRanks
Daily Progress: Bone Biologics Corp (BBLG) Drop -32.77, Closing at 0.80 - The Dwinnex
Bausch + Lomb explores sale amid parent company's debt woesreport By Investing.com - Investing.com Canada
Bausch + Lomb eyeing sale amid spinoff concerns (NYSE:BLCO) - Seeking Alpha
BBLG stock touches 52-week low at $1 amid steep annual decline - Investing.com
Financial Analysis: Sanara MedTech (NASDAQ:SMTI) vs. Bone Biologics (NASDAQ:BBLG) - Defense World
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033 - GlobeNewswire
Orthobiologics Market 2024 Development Plans – Medtronic, Bone Biologics Corp, Pioneer Surgical Technology, Bioventus LLC – Cauverynews - Cauverynews
Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Orthobiologics Industry to Witness Massive Growth (2024-2031) - openPR
LifeNet launches newest bone allograft gel with Johnson & Johnson - Medical Device Network
LifeNet launches newest bone allograft gel with Johnson & Johnson - Yahoo Finance
Perception Capital Corp. III (NASDAQ:PFTAU) Trading 7.4% Higher - Defense World
Bone Void Fillers Market Players In New Report By Top Research Firm - WhaTech
Cormark Research Analysts Boost Earnings Estimates for Equinox Gold Corp. (NYSEAMERICAN:EQX) - Defense World
Bone Biologics Co. (NASDAQ:BBLG) Expected to Earn Q3 2024 Earnings of ($0.60) Per Share - Defense World
Q3 2024 EPS Estimates for American Vanguard Co. Reduced by Analyst (NYSE:AVD) - Defense World
Cetera Advisors LLC Takes $423,000 Position in Despegar.com, Corp. (NYSE:DESP) - Defense World
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Amgen sues Samsung biotech unit over bone drug copies - Reuters
Vanguard Group Inc. Acquires 3,821 Shares of Southern Missouri Bancorp, Inc. (NASDAQ:SMBC) - Defense World
Ortho Biological Products Industry Giants Spending Is Going to Boom - அக்னி செய்திகள்
Orthobiologics Market Size | Share and Trends 2024 to 2034 - Precedence Research
Orthobiologics Market Growth Research Report 2024-2032| 250 Pages - EIN News
Bone Biologics announces warrant exercise deal - Investing.com
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - StockTitan
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):